Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $346.78 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $88.45 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $49.71 | 2 | $0 (2019) |
| GENZYME CORPORATION | $48.17 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $43.41 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $40.56 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $26.84 | 1 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.13 | 1 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $23.51 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $160.45 | 7 | Novartis Pharmaceuticals Corporation ($43.41) |
| 2019 | $186.33 | 8 | AbbVie, Inc. ($88.45) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Dermatology | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2019 | GENZYME CORPORATION | DERMATITIS - DISEASE (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $20.12 | General |
| 06/05/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
| 05/28/2019 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Immunology | ||||||
| 03/20/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Immunology | ||||||
| 03/18/2019 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Immunology | ||||||
| 02/13/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 112 | 179 | $16,516 | $8,486 |
| 2022 | 1 | 23 | 28 | $3,162 | $1,780 |
| 2021 | 2 | 25 | 30 | $3,893 | $2,326 |
| 2020 | 3 | 38 | 46 | $6,463 | $2,682 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 60 | $6,775 | $3,881 | 57.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 23 | 35 | $3,689 | $1,686 | 45.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 11 | 16 | $2,960 | $1,487 | 50.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 16 | 17 | $2,635 | $1,198 | 45.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 16 | 51 | $456.96 | $233.26 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 28 | $3,162 | $1,780 | 56.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 18 | $2,033 | $1,236 | 60.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 11 | 12 | $1,860 | $1,090 | 58.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 14 | 18 | $2,790 | $1,322 | 47.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $1,881 | $763.86 | 40.6% |
| 17000 | Destruction of skin growth | Office | 2020 | 13 | 17 | $1,792 | $595.57 | 33.2% |
About Dr. Freya Meyer, M.D
Dr. Freya Meyer, M.D is a Dermatology healthcare provider based in Palm Harbor, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2015. The National Provider Identifier (NPI) number assigned to this provider is 1619359320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Freya Meyer, M.D has received a total of $346.78 in payments from pharmaceutical and medical device companies, with $160.45 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($346.78).
As a Medicare-enrolled provider, Meyer has provided services to 198 Medicare beneficiaries, totaling 283 services with total Medicare billing of $15,273. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Palm Harbor, FL
- Active Since 06/18/2015
- Last Updated 03/21/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1619359320
Products in Payments
- Humira (Biological) $88.45
- DUPIXENT (Drug) $77.76
- COSENTYX (Drug) $43.41
- LIBTAYO (Biological) $40.56
- TREMFYA (Drug) $26.84
- Winlevi (Drug) $26.13
- Zoryve (Drug) $23.51
- DERMATITIS - DISEASE (Drug) $20.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.